#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Immunohistochemical Analysis of Pars Tensa Retraction Pocket in Children


Authors: M. Urík 1,2;  P. Hurník 3,4 ;  D. Žiak 3,4;  J. Macháč 1,2;  I. Šlapák 1,2;  O. Motyka 5;  J. Dvořáčková 3;  P. Jabandžiev 6
Authors‘ workplace: Klinika dětské otorinolaryngologie, Lékařská fakulta, Masarykova univerzita, Brno 1;  Fakultní nemocnice Brno 2;  Ústav patologie, Lékařská fakulta, Ostravská univerzita, Ostrava a FN Ostrava 3;  CGB laboratoře, Ostrava, Vítkovice 4;  Centrum nanotechnologií, VŠB-Technická univerzita, Ostrava 5;  Pediatrická klinika LF MU a FN Brno 6
Published in: Otorinolaryngol Foniatr, 66, 2017, No. 4, pp. 198-204.
Category: Original Article

Overview

Introduction:
Immunohistochemical analysis of pars tensa retraction pocket in children. Identification of signs typical for cholesteatoma and to support the retraction theory of cholesteatoma.

Methods:
Standard process of immunohistochemistry of retraction pockets. For immunohistochemistry we used CD45 LCA (Leukocyte common antigen), CD31 (platelet and endothelial cell adhesion molecule), D2-40 (podoplanin - lymphatic vessels) MMP9 (matrix metalloproteinase 9 - degradation of extracellular matrix) Ki67 (nuclear proliferation).

Results:
In all parameters, except for MMP9, we observed a significantly higher incidence in stage III retraction pockets than at II.

Conclusion:
We have described the immunohistochemical features of the pars tensa retraction pocket of the ear drum in children leading to cholesteatoma. All observed signs occur in the structure of the matrix and perimatrix cholesteatoma. For all monitored parameters except for MMP9, we showed a significantly higher incidence in stage III retraction pockets than in stage II. This observation indicates that the retraction pocket is a progressive disease and that it is a precholesteatoma stage.

KEYWORDS:
retraction pocket, immunohistochemical analysis, cholesteatoma, childhood


Sources

1. Bluestone, C. D, Bluestone, M. B.: Eustachian tube: structure, function, role in otitis media. Hamilton, Lewiston, N. Y., Decker, B. C., 2005. 219 s.

2. Bluestone, C. D. (ed): Pediatric otolaryngology. 4th ed. Philadelphia: Saunders; 2003. 1842 s.

3. Dornelles, C., Costa, S. S., Neuder, L., Rosito, L. P. S., Silva, A. R., Alves, S. L.: Comparison of acquired cholesteatoma between pediatric and adult patients. Eur. Arch. Oto-Rhino-Laryngol., off J. Eur. Fed. Oto-Rhino-Laryngol. Soc. EUFOS Affil Ger Soc. Oto-Rhino-Laryngol. - Head Neck Surg,. 266, 2009, 10, s. 1553-1561.

4. Dornhoffer, J. L.: Surgical management of the atelectatic ear. Am. J. Otol., 21, 2000, 3, s. 315-321.

5. Ergün, S., Zheng, X., Carlsöö, B.: Antigen expression of epithelial markers, collagen IV and Ki67 in middle ear cholesteatoma. An immunohistochemical Study. Acta Otolaryngol. (Stockh), 114, 1994, 3, s, 295-302.

6. Falk, B., Magnuson, B.: Eustachian tube closing failure in children with persistent middle ear effusion. Int. J. Pediatr. Otorhinolaryngol., 7, 1984, 2, s. 97-106.

7. Finch, P. W., Rubin, J. S., Miki, T., Ron, D., Aaronson, S. A.: Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science, 245, 245, 1989, 4919, s. 752-755.

8. Gerber, M. J., Mason, J. C., Lambert, P. R.: Hearing results after primary cartilage tympanoplasty. The Laryngoskope, 110, 2000, 12, s. 1994-1999.

9. Holmquist, J., Renvall, U., Svendsen, P.: Eustachian tube function and retraction of the tympanic membrane. Ann. Otol. Rhinol. Laryngol., 89, 1980, s. 65-66.

10. Chrobok, V., Pellant, A., Profant, M.: Cholesteatom spánkové kosti. Havlíčkův Brod, Tobiáš; 2008, 315 s.

11. Jin, B. J., Min, H. J., Neony, J. H., Park, C. W., Lee, S. H.: Expression of EGFR and microvessel density in middle ear cholesteatoma. Clin. Exp. Otorhinolaryngol., 4, 2011, 2, s. 67-71.

12. Kemppainen, H. O., Puhakka, H. J., Laippala, P. J., Sipilä, M. M., Manninen, M. P., Karma, P. H.: Epidemiology and aetiology of middle ear cholesteatoma. Acta Otolaryngol. (Stockh), 116, 1999, 5, s. 568-572.

13. Kuczkowski, J., Bakowska, A., Mikaszewski, B.: Immuno­morphological evaluation of cholesteatoma. Otolaryngol. Pol. Pol. Otolaryngol., 58, 2004, 2, s. 289-295.

14. Barchese, C., Rubin, J., Ron, D., Faggioni, A., Torrisi, M. R., Mesina, A. et al.: Human keratinocyte growth factor activity on proliferation and differentiation of human keratinocytes: differentiation response distinguishes KGF from EGF family. J. Cell Physiol., 144, 1990, 2, s. 326-332.

15. Miyashita, T., Burford, J. L., Hong, Y. K., Gevorgyan, H., Lam, L., Mori, N. et al.: Localization and proliferation of lymphatic vessels in the tympanic membrane in normal state and regeneration. Biochem. Biophys. Res. Commun, 440, 2013, 3, s. 371-373.

16. Nagai, T., Kano, K., Nagai, M., Morimitsu, T.: The ultrastructure of lymphatic vessels in the human middle ear with cholesteatoma. Acta Otolaryngol. (Stockh), 108, 1989, 5–6, s. 442-447.

17. Nagai, T., Suganuma, T., Ide, S., Shimoda, H., Kato, S.: Confirmation of mucin in lymphatic vessels of acquired cholesteatoma. Eur. Arch. Oto-Rhino-Laryngol. off J. Eur. Fed. Oto-Rhino-Laryngol. Soc. EUFOS Affil Ger Soc Oto-Rhino-Laryngol. - Head Neck Surg., 263, 2006, 4, s. 361-364.

18. Olszewska, E., Matulka, M., Mroczko, B., Pryczynicz, A., Kemona, A., Szmitkowski, M. et al.: Diagnostic value of matrix metalloproteinase 9 and tissue inhibitor of matrix metalloproteinases 1 in cholesteatoma. Histol. Histopathol., 31, 2016, 3, s. 307-315.

19. Rafla, S., Leone, L., Scrofani, C., Monini S., Torrisi, M. R., Barbara M.: Cholesteatoma-associated fibroblasts modulate epithelial growth and differentiation through KGF/FGF7 secretion. Histochem Cell Biol., 138, 2012, 2, s. 251-269.

20. SADE, J.: Atelectatic tympanic membrane: histologic study. Ann. Otol. Rhinol. Laryngol., 102, 1993, s. 712-716.

21. Shunyu, N. B., Gusta, S. D., Thakar, A., Sharma, S. C.: Histological and immunohistochemical study of pars tensa retraction pocket. Otolaryngol.-Head Neck Surg., off J. Am. Acad. Otolaryngol.-Head Neck Surg., 145, 2011, 4, s. 628-634.

22. Schilling, V., Bujía, J., Negri, B., Schulz, P., Kastenbauer, E.: Immunologically activated cells in aural cholesteatoma. Am. J. Otolaryngol., 12, 1991, 5, s. 249-253.

23. Sikka, K., Sharma, S. C., Thakar, A., Dattagupta, S.: Evaluation of epithelial proliferation in paediatric and adult cholesteatomas using the Ki-67 proliferation marker. J. Laryngol. Otol., 126, 2012, 5, s. 460-463.

24. Sudhoff, H., Tos, M.: Pathogenesis of attic cholesteatoma: clinical and immunohistochemical support for combination of retraction theory and proliferation theory. Am. J. Otol., 21, 2000, 6, s. 786-792.

25. Sudhoff, H., Tos, M.: Pathogenesis of sinus cholesteatoma. Eur. Arch. Oto-Rhino-Laryngol. off J. Eur. Fed. Oto-Rhino-Laryngol. Soc. EUFOS Affil Ger Soc Oto-Rhino-Laryngol. - Head Neck Surg., 264, 2007, 10, s. 1137-1143.

26. Urík, M., Hurník, P., Žiak, D., Machač, J., Šlapák, I., Motyka, O. et al.: Histological analysis of retraction pocket pars tensa of tympanic membrane in children. Int. J. Pediatr. Otorhinolaryngol., 86, 2016; s. 213-217.

27. Yamamoto-Fukuda, Tomomi, Haruo Takahashi, Mariko Terakado, Yoshitaka Hishikawa, Takehiko Koji: Expression of keratinocyte growth factor and Its: Receptor in noncholesteatomatous and cholesteatomatous chronic otitis media. Otology & Neurotology [online], 31, 2010, 5, s. 745-751.

Labels
Audiology Paediatric ENT ENT (Otorhinolaryngology)
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#